Gilead to buy biotech firm Ouro Medicines in over $2 billion deal


March 23 (Reuters) – ‌Gilead ‌Sciences said ​on Monday it ‌would ⁠buy privately ⁠held ​biotech ​firm ​Ouro ‌Medicines in a deal ‌worth ​up ​to $2.18 ​billion.

(Reporting ‌by Mariam ​Sunny ​in ​Bengaluru; ‌Editing by ​Shilpi ​Majumdar)



Source link

  • Related Posts

    What to know about the deadly collision between a jet and fire truck at NYC’s LaGuardia Airport

    NEW YORK (AP) — A jet landing at New York City’s LaGuardia Airport collided with a fire truck on the runway, killing the pilot and copilot and injuring several others.…

    Senators introduce bill to ban sports betting on prediction markets

    A bill introduced in the Senate on Monday would ban prediction markets like Kalshi and Polymarket from accepting or listing transactions related to sports events and casino-style games. The bill,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    NTSB Team Still En Route To LaGuardia: Delayed By TSA Lines

    NTSB Team Still En Route To LaGuardia: Delayed By TSA Lines

    LaGuardia crash underscores pressures on already strained air traffic control workforce

    LaGuardia crash underscores pressures on already strained air traffic control workforce

    What to know about the deadly collision between a jet and fire truck at NYC’s LaGuardia Airport

    What to know about the deadly collision between a jet and fire truck at NYC’s LaGuardia Airport

    Catastrophic flooding in Hawaii is worst seen in 20 years

    Catastrophic flooding in Hawaii is worst seen in 20 years

    Mechs And Turn-Based RPG Combat Collide In ‘Starbites’ On Switch 1 & 2 This May

    Mechs And Turn-Based RPG Combat Collide In ‘Starbites’ On Switch 1 & 2 This May

    One dead following avalanche near B.C.-Alaska border

    One dead following avalanche near B.C.-Alaska border